Table 3 shows the answers of the evaluation of the patient informed consent by patients undergoing radiotherapy and randomly selected males not undergoing radiotherapy (non-patients)
| Â | In total | Fully agree (1) | Partially Agree (2) | Neutral (3) | Partially disagree (4) | Fully disagree | No answer | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The PIC … |  | Patients | Non-Patients | Patients | Non-Patients | Patients | Non-Patients | Patients | Non-Patients | Patients | Non-Patients | Patients | Non-Patients |
is comprehensible | 10 | 60% | 50% | 40% | 40% | 0% | 10% | 0% | 0% | 0% | 0% | 0% | 0% |
answers all relevant questions | 10 | 80% | 50% | 10% | 50% | 10% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
is clearly structuered | 10 | 70% | 80% | 30% | 10% | 0% | 10% | 0% | 0% | 0% | 0% | 0% | 0% |
explains the medical/therapeutic benefit of the trial | 10 | 70% | 80% | 30% | W20% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
explains the trial’s procedure | 10 | 90% | 70% | 10% | 20% | 0% | 10% | 0% | 0% | 0% | 0% | 0% | 0% |
explains personal benefits of participating in the trial | 10 | 80% | 60% | 20% | 40% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
explains personal risks of participating in the trial | 10 | 90% | 40% | 10% | 60% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
explains treatment alternatives if the patient chooses not to participate in the trial | 10 | 70% | 40% | 10% | 50% | 0% | 0% | 10% | 0% | 10% | 10% | 0% | 0% |
explains the legal rights of paticipating in the trial | 10 | 80% | 70% | 10% | 20% | 0% | 10% | 0% | 0% | 0% | 0% | 10% | 0% |
contains comprehensive figures | 10 | 60% | 70% | 40% | 30% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
containts figures, which support the presented information | 10 | 50% | 80% | 50% | 20% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
leaves the patient without open questions | 10 | 70% | 70% | 30% | 10% | 0% | 20% | 0% | 0% | 0% | 0% | 0% | 0% |